DIA 2013 49th Annual Meeting
Click here to go to the previous page
Global Clinical Trials: The Role of Emerging Markets
Track : Track 01: Clinical Operations
Program Code: 126
Date: Monday, June 24, 2013
Time: 2:30 PM to 4:00 PM  EST
Location: 206AB
CHAIR :
 Nancy Meyerson-Hess, MSc (SCHNON), Compound Development and Branding, Gruenenthal, Germany
SPEAKER (S):
Nancy Meyerson-Hess, MSc (SPKNON), Compound Development and Branding, Gruenenthal, Germany
 Guei-Jen Shieh, PhD (SPKSUP), Director, Clinical Group, National Research Program For Biopharmaceuticals, Taiwan
 Linda Martin, MBA (SPKNON), Principal and Founder, KMR Group Inc., United States
Description
Today's drug development relies on global clinical trials which include emerging markets. The symposium will address performance, best practices, strategies and challenges of undertaking global clinical trials. The speakers will provide examples from global clinical trials with a focus on reducing risks, optimizing strategy to improve site enrollment and overall performance, and experience from the Clinical Trial Consortium in the Asia Pacific region.